| The somatic genomic landscape of glioblastoma CW Brennan, RGW Verhaak, A McKenna, B Campos, H Noushmehr, ... cell 155 (2), 462-477, 2013 | 5342 | 2013 |
| Genomic classification of cutaneous melanoma R Akbani, KC Akdemir, B áArman Aksoy, M Albert, A Ally, SB Amin, ... Cell 161 (7), 1681-1696, 2015 | 2883 | 2015 |
| Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function A Viale, P Pettazzoni, CA Lyssiotis, H Ying, N Sánchez, M Marchesini, ... Nature 514 (7524), 628-632, 2014 | 1272 | 2014 |
| Integrative genomic analysis of cholangiocarcinoma identifies distinct IDH-mutant molecular profiles F Farshidfar, S Zheng, MC Gingras, Y Newton, J Shih, AG Robertson, ... Cell reports 18 (11), 2780-2794, 2017 | 713 | 2017 |
| Emerging insights into the molecular and cellular basis of glioblastoma GP Dunn, ML Rinne, J Wykosky, G Genovese, SN Quayle, IF Dunn, ... Genes & development 26 (8), 756-784, 2012 | 685 | 2012 |
| Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma LN Kwong, JC Costello, H Liu, S Jiang, TL Helms, AE Langsdorf, ... Nature medicine 18 (10), 1503-1510, 2012 | 401 | 2012 |
| Passenger deletions generate therapeutic vulnerabilities in cancer FL Muller, S Colla, E Aquilanti, VE Manzo, G Genovese, J Lee, ... Nature 488 (7411), 337-342, 2012 | 385 | 2012 |
| Post-translational regulation of Cas9 during G1 enhances homology-directed repair T Gutschner, M Haemmerle, G Genovese, GF Draetta, L Chin Cell reports 14 (6), 1555-1566, 2016 | 336 | 2016 |
| Cutaneous manifestations in patients with COVID‐19: a preliminary review of an emerging issue AV Marzano, N Cassano, G Genovese, C Moltrasio, GA Vena British Journal of Dermatology 183 (3), 431-442, 2020 | 298 | 2020 |
| Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer P Dey, J Baddour, F Muller, CC Wu, H Wang, WT Liao, Z Lan, A Chen, ... Nature 542 (7639), 119-123, 2017 | 281 | 2017 |
| The RAC1 P29S hotspot mutation in melanoma confers resistance to pharmacological inhibition of RAF IR Watson, L Li, PK Cabeceiras, M Mahdavi, T Gutschner, G Genovese, ... Cancer research 74 (17), 4845-4852, 2014 | 186 | 2014 |
| Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis E Del Poggetto, IL Ho, C Balestrieri, EY Yen, S Zhang, F Citron, R Shah, ... Science 373 (6561), eabj0486, 2021 | 172 | 2021 |
| Oncogenic KRAS-driven metabolic reprogramming in pancreatic cancer cells utilizes cytokines from the tumor microenvironment P Dey, J Li, J Zhang, S Chaurasiya, A Strom, H Wang, WT Liao, ... Cancer discovery 10 (4), 608-625, 2020 | 165 | 2020 |
| Evidence for a ‘window of opportunity’in hidradenitis suppurativa treated with adalimumab: a retrospective, real‐life multicentre cohort study AV Marzano, G Genovese, G Casazza, C Moltrasio, P Dapavo, G Micali, ... British Journal of Dermatology 184 (1), 133-140, 2021 | 150 | 2021 |
| European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology–Part II E Schmidt, H Rashid, AV Marzano, A Lamberts, G Di Zenzo, GFH Diercks, ... Journal of the European Academy of Dermatology and Venereology 35 (10), 1926 …, 2021 | 144 | 2021 |
| In vivo functional platform targeting patient-derived xenografts identifies WDR5-Myc association as a critical determinant of pancreatic cancer A Carugo, G Genovese, S Seth, L Nezi, JL Rose, D Bossi, A Cicalese, ... Cell reports 16 (1), 133-147, 2016 | 143 | 2016 |
| Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients AV Marzano, G Genovese, G Casazza, MT Fierro, P Dapavo, N Crimi, ... Journal of the European Academy of Dermatology and Venereology 33 (5), 918-924, 2019 | 136 | 2019 |
| Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer G Genovese, A Carugo, J Tepper, FS Robinson, L Li, M Svelto, L Nezi, ... Nature 542 (7641), 362-366, 2017 | 132 | 2017 |
| microRNA regulatory network inference identifies miR-34a as a novel regulator of TGF-β signaling in glioblastoma G Genovese, A Ergun, SA Shukla, B Campos, J Hanna, P Ghosh, ... Cancer discovery 2 (8), 736-749, 2012 | 126 | 2012 |
| Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma Z Bakouny, DA Braun, SA Shukla, W Pan, X Gao, Y Hou, A Flaifel, S Tang, ... Nature communications 12 (1), 808, 2021 | 120 | 2021 |
Giulio DraettaThe University of Texas MD Anderson Cancer CenterVerified email at mdanderson.org
